Linde India (523457) Q4 01/02 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 01/02 earnings summary
27 Oct, 2026Executive summary
FY02 sales rose 1% to Rs 3,037.9m; operating profit after depreciation and interest, before extraordinary items, increased 97% to Rs 35.5m.
Net profit was Rs 25.8m, including a Rs 15m prior-year tax provision write-back; accumulated losses were expected to be eliminated in FY03.
Cost controls, productivity gains, lower interest expense and working-capital improvements supported results despite weak industrial demand.
Financial highlights
Sales were Rs 3,037.9m versus Rs 3,013.7m in FY01; operating profit before extraordinary items was Rs 35.518m versus Rs 18.065m.
PBT was Rs 10.775m after net extraordinary charges of Rs 24.743m; PAT was Rs 25.775m versus Rs 18.065m.
Extraordinary items included a Rs 130.299m Jamshedpur power fuel surcharge charge and Rs 105.556m gain on Mumbai property disposal.
The Rs 15m excess tax provision write-back related to favourable assessments for prior years; EPS was Rs 0.53 basic and diluted versus Rs 0.37.
Other income rose to Rs 48.396m from Rs 28.989m; expenses increased to Rs 2,017.563m from Rs 1,909.344m, including power and fuel costs of Rs 1,248.244m.
Outlook and guidance
FY03 outlook was cautiously optimistic, with expected steel-sector recovery and reasonable growth in automobile and two-wheeler markets supporting shielding gases.
Medical gases, Homecare, food freezing and fibre-optics applications were identified as growth opportunities to broaden the customer base.
Barring unforeseen circumstances, performance was expected to improve in FY03; accumulated losses were expected to be eliminated during the year.
Recent project wins were expected to add around Rs 600m to revenue over the following two years.
Latest events from Linde India
- Revenue grew, but Q2 consolidated profit and EPS fell YoY amid higher costs.523457
Q2 26/27 - Sales edged up, but profit fell as industrial weakness offset major capacity expansion.523457
Q4 96/97 - Healthcare sale gain offset operating losses as recession-driven weakness prompted restructuring.523457
Q4 97/98 - Higher revenue was outweighed by one-off provisions and the new plant’s financing burden.523457
Q4 99/00 - 14% turnover growth and restructuring returned the year to profit amid cautious outlook.523457
Q4 00/01 - FY03 profit surged, boosted by a property sale, as engineering growth offset gases-market pressure.523457
Q4 02/03 - Operating profit surged 76%; property gains lifted PBT as borrowings fell 26%.523457
Q4 03/04 - Record FY05 operating profit and project growth offset by lower one-off gains and higher taxes.523457
Q4 04/05 - Record sales and stronger operating profit, boosted by a property sale, alongside ambitious capacity expansion.523457
Q4 05/06